Brilinta just cleared the DOJ hurdle, and, "PEGASUS is assessing the use of Brilinta in patients who experienced a heart attack 1-3 years ago. If successful, this group could more than double the number patients eligible to receive the medicine." Pascal was right - it's going to take time, but worth holding out for. Unfortunately it just this kind of thing that makes Pfizer rear its ugly head...
Feel free to flame away.